Compile Data Set for Download or QSAR
Report error Found 444 Enz. Inhib. hit(s) with all data for entry = 11399
TargetAdenosine receptor A2b(Human)
Exelixis

US Patent
LigandPNGBDBM612125(1-[5-(furan-2-yl)-2-methyl- [1,2,4]triazolo[1,5- c...)
Affinity DataIC50: 10nMAssay Description:100 μL of Adenosine A2B membrane stock was dispensed into individual wells of an assay plate. 1 μL of each compound (test compounds, high c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Exelixis

US Patent
LigandPNGBDBM612125(1-[5-(furan-2-yl)-2-methyl- [1,2,4]triazolo[1,5- c...)
Affinity DataIC50: 10nMAssay Description:2 L of each compound (test compounds, high control compound, low control compound) was transferred into individual wells of an assay plate. Also, to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Exelixis

US Patent
LigandPNGBDBM612241(1-ethyl-3-[8-(furan-2-yl)-2- methylimidazo[1,2- a]...)
Affinity DataIC50: 10nMAssay Description:2 L of each compound (test compounds, high control compound, low control compound) was transferred into individual wells of an assay plate. Also, to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Exelixis

US Patent
LigandPNGBDBM612114(4-methyl-7-(5-methylfuran-2- yl)-3,5,6,8,10- penta...)
Affinity DataIC50: 10nMAssay Description:2 L of each compound (test compounds, high control compound, low control compound) was transferred into individual wells of an assay plate. Also, to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Exelixis

US Patent
LigandPNGBDBM612137(2-methyl-5-(5-methylfuran-2- yl)-8-propan-2-yl-3H-...)
Affinity DataIC50: 10nMAssay Description:2 L of each compound (test compounds, high control compound, low control compound) was transferred into individual wells of an assay plate. Also, to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Exelixis

US Patent
LigandPNGBDBM612138(7-(5-methylfuran-2-yl)-4- propan-2-yl-3,5,6,8,10,1...)
Affinity DataIC50: 10nMAssay Description:2 L of each compound (test compounds, high control compound, low control compound) was transferred into individual wells of an assay plate. Also, to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Exelixis

US Patent
LigandPNGBDBM612127(N-[5-(5-methylfuran-2-yl)-2- (oxetan-3-yl)- [1,2,4...)
Affinity DataIC50: 10nMAssay Description:2 L of each compound (test compounds, high control compound, low control compound) was transferred into individual wells of an assay plate. Also, to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Exelixis

US Patent
LigandPNGBDBM612126(N-[5-(5-methylfuran-2-yl)-2- (oxetan-3-yl)- [1,2,4...)
Affinity DataIC50: 10nMAssay Description:2 L of each compound (test compounds, high control compound, low control compound) was transferred into individual wells of an assay plate. Also, to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Exelixis

US Patent
LigandPNGBDBM612022(N-[2-methyl-5-(5- methylfuran-2-yl)- [1,2,4]triazo...)
Affinity DataIC50: 10nMAssay Description:2 L of each compound (test compounds, high control compound, low control compound) was transferred into individual wells of an assay plate. Also, to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetAdenosine receptor A2b(Human)
Exelixis

US Patent
LigandPNGBDBM612151(2-[4-methyl-7-(5-methylfuran- 2-yl)-3,5,6,8,10- pe...)
Affinity DataIC50: 10nMAssay Description:100 μL of Adenosine A2B membrane stock was dispensed into individual wells of an assay plate. 1 μL of each compound (test compounds, high c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetAdenosine receptor A2b(Human)
Exelixis

US Patent
LigandPNGBDBM612021(N-2-[(4- methoxyphenyl)methyl]-5-(5- methylfuran-2...)
Affinity DataIC50: 10nMAssay Description:100 μL of Adenosine A2B membrane stock was dispensed into individual wells of an assay plate. 1 μL of each compound (test compounds, high c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Exelixis

US Patent
LigandPNGBDBM612151(2-[4-methyl-7-(5-methylfuran- 2-yl)-3,5,6,8,10- pe...)
Affinity DataIC50: 10nMAssay Description:2 L of each compound (test compounds, high control compound, low control compound) was transferred into individual wells of an assay plate. Also, to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Exelixis

US Patent
LigandPNGBDBM612021(N-2-[(4- methoxyphenyl)methyl]-5-(5- methylfuran-2...)
Affinity DataIC50: 10nMAssay Description:2 L of each compound (test compounds, high control compound, low control compound) was transferred into individual wells of an assay plate. Also, to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetAdenosine receptor A2b(Human)
Exelixis

US Patent
LigandPNGBDBM612150(N-[2-(difluoromethyl)-5- (furan-2-yl)- [1,2,4]tria...)
Affinity DataIC50: 10nMAssay Description:100 μL of Adenosine A2B membrane stock was dispensed into individual wells of an assay plate. 1 μL of each compound (test compounds, high c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Exelixis

US Patent
LigandPNGBDBM612150(N-[2-(difluoromethyl)-5- (furan-2-yl)- [1,2,4]tria...)
Affinity DataIC50: 10nMAssay Description:2 L of each compound (test compounds, high control compound, low control compound) was transferred into individual wells of an assay plate. Also, to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Exelixis

US Patent
LigandPNGBDBM612024(2-ethyl-5-(5-methylfuran-2- yl)-[1,2,4]triazolo[1,...)
Affinity DataIC50: 10nMAssay Description:2 L of each compound (test compounds, high control compound, low control compound) was transferred into individual wells of an assay plate. Also, to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Exelixis

US Patent
LigandPNGBDBM612023(2,2-dimethyl-N-[2-methyl-5- (5-methylfuran-2-yl)- ...)
Affinity DataIC50: 10nMAssay Description:2 L of each compound (test compounds, high control compound, low control compound) was transferred into individual wells of an assay plate. Also, to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Exelixis

US Patent
LigandPNGBDBM612152(N-[5-(furan-2-yl)-2-(1- methylazetidin-3-yl)- [1,2...)
Affinity DataIC50: 10nMAssay Description:2 L of each compound (test compounds, high control compound, low control compound) was transferred into individual wells of an assay plate. Also, to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Exelixis

US Patent
LigandPNGBDBM612155(8-chloro-2-(fluoromethyl)-5- phenyl-[1,2,4]triazol...)
Affinity DataIC50: 10nMAssay Description:2 L of each compound (test compounds, high control compound, low control compound) was transferred into individual wells of an assay plate. Also, to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Exelixis

US Patent
LigandPNGBDBM612025(N-[2-ethyl-5-(5-methylfuran- 2-yl)-[1,2,4]triazolo...)
Affinity DataIC50: 10nMAssay Description:2 L of each compound (test compounds, high control compound, low control compound) was transferred into individual wells of an assay plate. Also, to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetAdenosine receptor A2b(Human)
Exelixis

US Patent
LigandPNGBDBM612028(8-chloro-2-methyl-5-(5- methylfuran-2-yl)- [1,2,4]...)
Affinity DataIC50: 10nMAssay Description:100 μL of Adenosine A2B membrane stock was dispensed into individual wells of an assay plate. 1 μL of each compound (test compounds, high c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Exelixis

US Patent
LigandPNGBDBM612028(8-chloro-2-methyl-5-(5- methylfuran-2-yl)- [1,2,4]...)
Affinity DataIC50: 10nMAssay Description:2 L of each compound (test compounds, high control compound, low control compound) was transferred into individual wells of an assay plate. Also, to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Exelixis

US Patent
LigandPNGBDBM612027(N-[2-methyl-5-(5- methylfuran-2-yl)- [1,2,4]triazo...)
Affinity DataIC50: 10nMAssay Description:2 L of each compound (test compounds, high control compound, low control compound) was transferred into individual wells of an assay plate. Also, to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Exelixis

US Patent
LigandPNGBDBM612156(N-[2-(fluoromethyl)-5-(furan- 2-yl)-[1,2,4]triazol...)
Affinity DataIC50: 10nMAssay Description:2 L of each compound (test compounds, high control compound, low control compound) was transferred into individual wells of an assay plate. Also, to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetAdenosine receptor A2b(Human)
Exelixis

US Patent
LigandPNGBDBM612143(N-[2-(difluoromethyl)-5-(5- methylfuran-2-yl)- [1,...)
Affinity DataIC50: 10nMAssay Description:100 μL of Adenosine A2B membrane stock was dispensed into individual wells of an assay plate. 1 μL of each compound (test compounds, high c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Exelixis

US Patent
LigandPNGBDBM612143(N-[2-(difluoromethyl)-5-(5- methylfuran-2-yl)- [1,...)
Affinity DataIC50: 10nMAssay Description:2 L of each compound (test compounds, high control compound, low control compound) was transferred into individual wells of an assay plate. Also, to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetAdenosine receptor A2b(Human)
Exelixis

US Patent
LigandPNGBDBM612144(N-[2-(fluoromethyl)-5-(5- methylfuran-2-yl)- [1,2,...)
Affinity DataIC50: 10nMAssay Description:100 μL of Adenosine A2B membrane stock was dispensed into individual wells of an assay plate. 1 μL of each compound (test compounds, high c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Exelixis

US Patent
LigandPNGBDBM612144(N-[2-(fluoromethyl)-5-(5- methylfuran-2-yl)- [1,2,...)
Affinity DataIC50: 10nMAssay Description:2 L of each compound (test compounds, high control compound, low control compound) was transferred into individual wells of an assay plate. Also, to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Exelixis

US Patent
LigandPNGBDBM612018(2-Methyl-5-(5-methylfuran-2- yl)-[1,2,4]triazolo[1...)
Affinity DataIC50: 10nMAssay Description:2 L of each compound (test compounds, high control compound, low control compound) was transferred into individual wells of an assay plate. Also, to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetAdenosine receptor A2b(Human)
Exelixis

US Patent
LigandPNGBDBM612019(N-[2-methyl-5-(5- methylfuran-2-yl)- [1,2,4]triazo...)
Affinity DataIC50: 10nMAssay Description:100 μL of Adenosine A2B membrane stock was dispensed into individual wells of an assay plate. 1 μL of each compound (test compounds, high c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Exelixis

US Patent
LigandPNGBDBM612019(N-[2-methyl-5-(5- methylfuran-2-yl)- [1,2,4]triazo...)
Affinity DataIC50: 10nMAssay Description:2 L of each compound (test compounds, high control compound, low control compound) was transferred into individual wells of an assay plate. Also, to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Exelixis

US Patent
LigandPNGBDBM612148(N-[5-(3-fluorophenyl)-2- methyl-[1,2,4]triazolo[1,...)
Affinity DataIC50: 10nMAssay Description:2 L of each compound (test compounds, high control compound, low control compound) was transferred into individual wells of an assay plate. Also, to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Exelixis

US Patent
LigandPNGBDBM612038(5-(5-methylfuran-2-yl)-2- (trifluoromethyl)- [1,2,...)
Affinity DataIC50: 10nMAssay Description:2 L of each compound (test compounds, high control compound, low control compound) was transferred into individual wells of an assay plate. Also, to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Exelixis

US Patent
LigandPNGBDBM612038(5-(5-methylfuran-2-yl)-2- (trifluoromethyl)- [1,2,...)
Affinity DataIC50: 10nMAssay Description:2 L of each compound (test compounds, high control compound, low control compound) was transferred into individual wells of an assay plate. Also, to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetAdenosine receptor A2b(Human)
Exelixis

US Patent
LigandPNGBDBM612037(N-[5-(5-methylfuran-2-yl)-2- (trifluoromethyl)- [1...)
Affinity DataIC50: 10nMAssay Description:100 μL of Adenosine A2B membrane stock was dispensed into individual wells of an assay plate. 1 μL of each compound (test compounds, high c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Exelixis

US Patent
LigandPNGBDBM612166(N-[2-(fluoromethyl)-5-(furan- 2-yl)-[1,2,4]triazol...)
Affinity DataIC50: 10nMAssay Description:2 L of each compound (test compounds, high control compound, low control compound) was transferred into individual wells of an assay plate. Also, to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Exelixis

US Patent
LigandPNGBDBM612043(7-amino-2-methyl-5-(5- methylfuran-2-yl)- [1,2,4]t...)
Affinity DataIC50: 10nMAssay Description:2 L of each compound (test compounds, high control compound, low control compound) was transferred into individual wells of an assay plate. Also, to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetAdenosine receptor A2b(Human)
Exelixis

US Patent
LigandPNGBDBM612042(N-[2-methyl-5-(5- methylfuran-2-yl)- [1,2,4]triazo...)
Affinity DataIC50: 10nMAssay Description:100 μL of Adenosine A2B membrane stock was dispensed into individual wells of an assay plate. 1 μL of each compound (test compounds, high c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Exelixis

US Patent
LigandPNGBDBM612042(N-[2-methyl-5-(5- methylfuran-2-yl)- [1,2,4]triazo...)
Affinity DataIC50: 10nMAssay Description:2 L of each compound (test compounds, high control compound, low control compound) was transferred into individual wells of an assay plate. Also, to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Exelixis

US Patent
LigandPNGBDBM612170(7-(5-methylfuran-2-yl)-4- (trifluoromethyl)- 3,5,6...)
Affinity DataIC50: 10nMAssay Description:2 L of each compound (test compounds, high control compound, low control compound) was transferred into individual wells of an assay plate. Also, to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Exelixis

US Patent
LigandPNGBDBM612173(1-[5-(furan-2-yl)-2-methyl- [1,2,4]triazolo[1,5- c...)
Affinity DataIC50: 10nMAssay Description:2 L of each compound (test compounds, high control compound, low control compound) was transferred into individual wells of an assay plate. Also, to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetAdenosine receptor A2b(Human)
Exelixis

US Patent
LigandPNGBDBM612043(7-amino-2-methyl-5-(5- methylfuran-2-yl)- [1,2,4]t...)
Affinity DataIC50: 10nMAssay Description:100 μL of Adenosine A2B membrane stock was dispensed into individual wells of an assay plate. 1 μL of each compound (test compounds, high c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Exelixis

US Patent
LigandPNGBDBM612030(5-(5-methylfuran-2-yl)-2- propan-2-yl- [1,2,4]tria...)
Affinity DataIC50: 10nMAssay Description:2 L of each compound (test compounds, high control compound, low control compound) was transferred into individual wells of an assay plate. Also, to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetAdenosine receptor A2b(Human)
Exelixis

US Patent
LigandPNGBDBM612029(N-[5-(5-methylfuran-2-yl)-2- propan-2-yl- [1,2,4]t...)
Affinity DataIC50: 10nMAssay Description:100 μL of Adenosine A2B membrane stock was dispensed into individual wells of an assay plate. 1 μL of each compound (test compounds, high c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Exelixis

US Patent
LigandPNGBDBM612029(N-[5-(5-methylfuran-2-yl)-2- propan-2-yl- [1,2,4]t...)
Affinity DataIC50: 10nMAssay Description:2 L of each compound (test compounds, high control compound, low control compound) was transferred into individual wells of an assay plate. Also, to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetAdenosine receptor A2b(Human)
Exelixis

US Patent
LigandPNGBDBM612161(2,2-difluoro-N-[5-(furan-2-yl)- 2-methyl-[1,2,4]tr...)
Affinity DataIC50: 10nMAssay Description:100 μL of Adenosine A2B membrane stock was dispensed into individual wells of an assay plate. 1 μL of each compound (test compounds, high c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Exelixis

US Patent
LigandPNGBDBM612032(N-[8-chloro-2-methyl-5-(5- methylfuran-2-yl)- [1,2...)
Affinity DataIC50: 10nMAssay Description:2 L of each compound (test compounds, high control compound, low control compound) was transferred into individual wells of an assay plate. Also, to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Exelixis

US Patent
LigandPNGBDBM612161(2,2-difluoro-N-[5-(furan-2-yl)- 2-methyl-[1,2,4]tr...)
Affinity DataIC50: 10nMAssay Description:2 L of each compound (test compounds, high control compound, low control compound) was transferred into individual wells of an assay plate. Also, to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Exelixis

US Patent
LigandPNGBDBM612031(N-[2-methyl-5-(5- methylfuran-2-yl)- [1,2,4]triazo...)
Affinity DataIC50: 10nMAssay Description:2 L of each compound (test compounds, high control compound, low control compound) was transferred into individual wells of an assay plate. Also, to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Exelixis

US Patent
LigandPNGBDBM612035(1-methyl-N-[2-methyl-5-(5- methylfuran-2-yl)- [1,2...)
Affinity DataIC50: 10nMAssay Description:2 L of each compound (test compounds, high control compound, low control compound) was transferred into individual wells of an assay plate. Also, to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

Displayed 1 to 50 (of 444 total ) | Next | Last >>
Jump to: